background image

Paid Clinical Trials Fort Wayne

Discover 114 paid clinical trials in Fort Wayne, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: 40 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting
Active & Responsive

Device Global Registry for the IlluminOss Bone Stabilization System

for
Traumatic Fracture, Pathological Fracture
Location: 11 recruiting locations
Sponsor: IlluminOss Medical, Inc.

Sex: All

Age: 50+

Code: NCT05206981

Recruiting
Active & Responsive

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for
Neoplasms, Head and Neck
Location: 28 recruiting locations
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06256588

Phase3, Recruiting
Active & Responsive

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: 99 recruiting locations
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting
Active & Responsive

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: 23 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

LGMD R1 Natural History Study

for
Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A,
Location: 9 recruiting locations
Sponsor: Virginia Commonwealth University

Sex: All

Age: 12 - 50

Code: NCT05618080

Recruiting
Active & Responsive

Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

for
Brain Metastases From Solid Tumors
Location: 5 recruiting locations
Sponsor: Radiopharm Theranostics, Ltd

Sex: All

Age: 18+

Code: NCT06777433

Phase2, Recruiting
Active & Responsive

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: 76 recruiting locations
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

for
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion,
Location: 25 recruiting locations
Sponsor: Bayer

Sex: All

Age: 0+

Code: NCT04142437

Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: 23 recruiting locations
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase1, Recruiting